ARTICLE | Company News
MD Anderson licenses OX40 antibodies to GSK
December 8, 2012 1:35 AM UTC
The University of Texas MD Anderson Cancer Center (Houston, Texas) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to develop and commercialize antibodies that activate tum...